Floatz logo

Naproxen

Arthralgia

Probity Medical ResearchSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Arthralgia cohort.

Asset / SponsorPhaseRating
DICLOFENAC
Express Specialty Pharmacy
Phase 4BBB
TESTOSTERONE UNDECYLATE
Alliance for Clinical Trials in Oncology
Phase 3BB
Letrozole
ARKAY Therapeutics
Phase 2BB
Tapentadol
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3B
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
British Columbia Cancer Agency
Phase 2/3B

View all 16 →

Same molecule, other indications

Naproxen is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →